Eton Pharmaceuticals, Inc. (ETON) stock
ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3089% above fair value
$63.93+2.48 (+4.04%)
Close on Nov 13, 2026Market cap $1.83BP/E 42.1Yield –
Eton Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Eton Pharmaceuticals's enterprise value was $1.94B on Nov 11, 2026, against $426.35M a year earlier. Over the last 5 years it ranged from $36.39M to $1.94B, with a median of $98.30M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.94B | +333.4% |
| 2025 | Dec 31, 2025 | $446.73M | +36.2% |
| 2024 | Dec 31, 2024 | $328.00M | +257.1% |
| 2023 | Dec 29, 2023 | $91.85M | +56.6% |
| 2022 | Dec 30, 2022 | $58.67M | -30.1% |
| 2021 | Dec 31, 2021 | $83.94M | -48.6% |
| 2020 | Dec 31, 2020 | $163.30M | +40.3% |
| 2019 | Dec 31, 2019 | $116.43M | +270.1% |
| 2018 | Dec 31, 2018 | $31.46M | – |
See a number that looks wrong?